Low/Intermediate PCa Video Chat, Feb 24, 2025

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostics.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:

Men (Only) Speaking Freely…1st & 3rd Thursdays @ 8.00 pm Eastern https://ancan.org/men-speaking-freely/
Veterans Healthcare Navigation… 1st & 3rd Tuesdays @ 8.00 pm Eastern https://ancan.org/veterans/

AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.

AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.

AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download

AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.

All AnCan’s groups are free and drop-in … join us in person sometime!

You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/
Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Editor’s Pick: Medicare patients can receive telehealth services for non-behavioral/mental health care in their home through March 31, 2025. (bj)

Topics Discussed
Decision point for transitioning from active surveillance to treatment; DECIPHER; DECIPHER Grid Report; Medicare stopping telehealth on March 31, 2025; PROMISE STUDY; BRCA1 mutation; BRCA patients have increased radiation sensitivity; PSA bumps; biochemical recurrence; weaving is therapy; 2025 ASCO GU update.

Chat Log

Michael – TN
If having trouble getting response via email from Dr Epstein: —- Gabriella Deliguori, MHA Administrative Supervisor 516-280-7930

Michael – TN
gdeliguori@imppllc.com

Mark Perloe
https://advanceduropathology.com/ gdeliguori@imppllc.com

Bill Nieusma (VA)
will Dr. Epstein require imagery or just a report?

AnCan – rick
uro… David Penson at Vanderbilt https://www.vanderbilthealth.com/doctors/penson-david

Boykin
Telehealth Policy Update (HHS) https://telehealth.hhs.gov/providers/telehealth-policy/telehealth-policy-updates

AnCan – rick
Clinical Trial NCT05498272 https://www.clinicaltrials.gov/study/NCT05498272?cond=Prostate%20Cancer&term=Prostatectomy&aggFilters=status:rec%20not&intr=PARP&rank=2

AnCan – rick
PROMISE link – please jump on this…. https://www.prostatecancerpromise.org/?utm_campaign=ANCAN&utm_medium=link&utm_source=Webinar

AnCan – rick
SAH Link for Wednesday night https://ancan.org/solo-arts-heal/

Jim Stewart
good night all…signing off for grandkid duty

Michael – TN
ming.zhou@mountsinai.org – Dr Ming Zhou 212-241-5227

AnCan – rick
Dr. Zhou, Mount Sinai

Tim in Tampa
I’m in the boring stage…thankfully

Low/Intermediate PCa Video Chat, Feb 24, 2025